Mimosa Pudica Seed Extract: Line 1 of FemiCore's Herbal Blend

Mimosa pudica seed extract is a concentrate made from the seeds of a low, creeping plant in the pea family. Its common name, the sensitive plant, comes from the way its small leaflets fold shut when touched.

FemiCore prints it as "Mimosa pudica Seed Extract" and nothing more. There is no extract ratio, no solvent and no marker compound. Compare the cranberry line just below it, which at least states 30% proanthocyanidin.

What the name on the label does and does not tell you

• The plant part: the seed, not the leaf or root.
• The form: an extract, so concentrated in some way.
• Not printed: how strong it is, or how it was made.

No. We found no human trial and no public health source that supports Mimosa pudica seed as a parasite or gut cleanse. Those claims come from online sellers, not from FemiCore's label.

Seed products are often sold that way, with talk of the seeds swelling into a gel that sweeps the gut. That story is marketing until a controlled human study shows it. The FTC expects health claims to rest on that kind of evidence (FTC, Health Products Compliance Guidance).

Mimosa pudica seed is the first of nine lines and the first of four herbs. After it come cranberry, bearberry leaf and berberine, then five probiotic strains in a separate 50 mg blend.

See every line side by side on the FemiCore ingredients page.

1. 21 CFR 101.36 - Nutrition labeling of dietary supplements. Electronic Code of Federal Regulations (eCFR), 2026.Under paragraph (c), a proprietary blend is labeled 'Proprietary Blend' or similar and its quantity is the total weight of its dietary ingredients. The ingredients inside are listed by weight in descending order of predominance, indented under the blend name, without a separate amount for each ingredient.
2. Using Dietary Supplements Wisely. National Center for Complementary and Integrative Health (NIH), 2019.'Natural' does not always mean safe. Supplements can interact with medicines, some raise bleeding risk or affect anesthesia (tell providers well before surgery), and many have not been tested in pregnant or nursing women or children. Some products sold as supplements contain undeclared prescription drugs; stop a supplement and call a provider if side effects occur, and report concerns through the HHS Safety Reporting Portal.
3. Health Products Compliance Guidance. Federal Trade Commission, 2022.Published December 20, 2022. Health-benefit claims generally need competent and reliable scientific evidence, meaning randomized, controlled human clinical testing; animal and in vitro studies alone are insufficient and observational studies do not prove causation. Testimonials need the same substantiation as the claim, consumer experiences alone are never sufficient, and a 'Results not typical' disclaimer does not cure a deceptive testimonial.
4. How to Report a Problem with Dietary Supplements. U.S. Food and Drug Administration, 2025.If a supplement may have caused a serious reaction, stop using it immediately and report through the Safety Reporting Portal (safetyreporting.hhs.gov); partial information still helps. Serious reactions FDA lists include hives or throat swelling, fainting, severe GI symptoms, trouble urinating or dark urine, blood in urine, yellowing of the skin or eyes, and mood or behavior changes. Content current as of March 13, 2025.